Table 1. Design of the randomized, balanced cross-over design according to the condition (curcumin + piperine versus placebo) and the legs (dominant versus non-dominant).
First session Second session
Group 1 Dominant leg–curcumin + piperine Nondominant leg– placebo
Group 2 Non dominant leg–curcumin + piperine Dominant leg– placebo
Group 3 Dominant leg– placebo Nondominant leg– curcumin + piperine
Group 4 Nondominant leg– placebo Dominant leg–curcumin + piperine